Abstract
Obesity is a global problem with a rising prevalence, which has serious implications not only for individuals‘ health but also for society as a whole. The increased incidence of overweight and obesity leads to higher healthcare costs and limits the employment opportunities of individuals, affecting their quality of life.
The treatment of obesity encompasses various approaches, including diet, exercise, pharmacotherapy, and surgical bariatric procedures. New and promising methods of treatment include endoscopic sleeve gastroplasty (ESG). ESG offers a safe, minimally invasive method that reduces the volume of the stomach and has long-term results in terms of weight reduction.
Thanks to significant advances in the field of endoscopy and endoscopic suturing, we can expect new and improved devices to be used in ESG. This will make ESG even safer, less dependent on the expertise of physicians, and its outcomes will significantly approach those of traditional bariatric surgery.
doi: 10.48095/ccrvch2024331